JNJ

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Johnson & Johnson

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.
CEO
Alex Gorsky
Employees
134500
Headquarters

1 Johnson And Johnson Plz
New Brunswick, New Jersey 08933-0001
Phone: 17325242455
www.jnj.com

News

7 Stocks That Win When the Fed Hikes Interest Rates
Aug 18, 2022 16:59pm

As the saying goes, past is not prologue. That simply means that what happened in the past doesn’t fully predict what will occur in the future. But when it comes to the stock market, there’s strong data to suggest that when the Fed hikes interest rates, certain sectors fare much better than others. Therefore, investors would be wise to focus on those sectors when picking stocks to buy. The data, compiled by Charles Schwab , indicates that six sectors , including communication services, energy, financials, healthcare, information technology, and utilities, outperform the stock market following rate hikes. So one strategy would simply be to find strong performers from each of those sectors and buy the shares of those stocks. I’ll identify such stocks in this column. CTRA Coterra Energy $30.20 MSFT Microsoft $290.50 V Visa $214.90 MA Mastercard $357.07 JNJ Johnson & Johnson $166.30 TMUS T-Mobile US $146.23 DUK Duke Energy $112.35 Coterra Energy (CTRA) Source: zhengzaishuru / Shutterstock.


Source:InvestorPlace
Mayar Capital’s Largest Holding: Johnson & Johnson (JNJ)
Aug 18, 2022 04:12am

Mayar Capital, an asset management firm, published its second-quarter 2022 investor letter – a copy of which can be downloaded here. For the three months ending March 31, 2021, Mayar Fund (Class A) was down 6.6% net of all expenses and fees, while the MSCI World Index declined by 5.2% in the same period. Since […]


Source:Insider Monkey
CVS, Walmart, Walgreens ordered to pay $650.6 million to Ohio counties in opioid case
Aug 18, 2022 02:00am

Pharmacy operators CVS, Walmart , and Walgreens must pay a combined $650.6 million to two Ohio counties to address the damage done by the opioid epidemic , a federal judge ruled Wednesday, August 17. The order by US District Judge Dan Polster in Cleveland marks the first time pharmacy chains have been ordered to pay money in an opioid lawsuit. It comes after a jury last November concluded that the companies helped create a public nuisance in Lake and Trumbull counties by oversupplying addictive pain pills, many of which found their way onto the black market. “The news today means that we will soon have the long-awaited resources necessary to extend aid to properly address the harms caused by this devastating epidemic,” Trumbull County Commissioner Frank Fuda said in a statement. The pharmacies, which have argued they cannot be liable for filling legal prescriptions from doctors, have said they would appeal that verdict. Representatives of Walgreens and CVS both said Wednesday’s decision was not supported by the law and that they planned to appeal it.


Source:Rappler
If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here''s How Much You''d Have Now
Aug 17, 2022 23:04pm

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom. Johnson & Johnson''s Bumpy Road: One company that has been a solid investment in the past two years has been pharmaceutical giant Johnson & Johnson (NYSE: JNJ ). Johnson & Johnson investors have likely been somewhat disappointed with the performance of the stock in the past two years given how much attention the company’s COVID-19 vaccine initially received. In addition, the company is facing a number of costly and potentially damaging legal battles. In October 2020, Johnson & Johnson agreed to settle more than 1,000 talcum powder lawsuits for $100 million. That same month, the company also agreed to add an additional $1 billion to its 2019 $4 billion settlement related to its role in the U.S. opioid crisis. At the beginning of 2020, Johnson & Johnson shares were trading at around $146.


Source:Benzinga
Stocks: Winners and Losers from the Strong Dollar
Aug 17, 2022 16:29pm

A strong dollar is a thorn in the side of U.S companies with a global footprint. Revenues earned overseas translate into fewer greenbacks here when the dollar is strengthening. And U.S. products become increasingly pricey for consumers abroad. Over the past year, the dollar is up more than 14% against a basket of foreign currencies, as measured by the U.S. Dollar Index ( DXY ). And if inflation stays high , more rate-hiking from the Federal Reserve to cool the economy and tame prices would likely push the dollar even higher. SEE MORE Warren Buffett Stocks Ranked: The Berkshire Hathaway Portfolio That has started to put a dent into U.S. corporate profits. During the second quarter earnings season companies including Johnson & Johnson ( JNJ ), IBM ( IBM ), Microsoft ( MSFT ), Netflix ( NFLX ) and Salesforce.com ( CRM ) have trimmed their outlooks for business results because of a beefier buck. Companies in the benchmark S&P 500 index generate about 30% of their revenues outside the U.S.


Source:Kiplinger
Johnson & Johnson stock rises Tuesday, outperforms market
Aug 16, 2022 20:32pm

Shares of Johnson & Johnson inched 0.89% higher to $167.57 Tuesday, on what proved to be an all-around great trading session for the stock market, with the…


Source:MarketWatch
AstraZeneca/Merck''s Lynparza gets FDA priority review to treat prostate cancer subtype
Aug 16, 2022 08:20am

The U.S. Food and Drug Administration ((FDA)) granted priority review to AstraZeneca (AZN) and Merck''s (MRK) medicine Lynparza in combination with Johnson & Johnson''s (JNJ)…


Source:Seeking Alpha
Top 5 2nd Quarter Trades of Evercore Wealth Management, LLC
Aug 16, 2022 01:00am

Related Stocks: GNRC , NVDA , NET , IDXX , JNJ ,


Source:GuruFocus
Technical Analysis: Johnson & Johnson
Aug 16, 2022 00:10am

Johnson & Johnson Technical Analysis Summary Sell Stop։ Below 166.95 Stop Loss: Above 171.82 Indicator Signal RSI Buy MACD Sell Donchian Channel Sell …


Source:FXStreet
Top 5 2nd Quarter Trades of Concorde Financial Corp
Aug 15, 2022 15:00pm

Related Stocks: MSFT , PXD , JNJ , HSY , SLB ,


Source:GuruFocus
SEEYOND Buys 3, Sells 2 in 2nd Quarter
Aug 15, 2022 15:00pm

Related Stocks: JNJ , TTWO , INCY , CBOE , BMY ,


Source:GuruFocus
J&J talc powder sold in Saudi Arabia is safe: SFDA
Aug 15, 2022 13:59pm

Riyadh: The Kingdom of Saudi Arabia’s Food and Drug Authority (SFDA) on Monday confirmed that Johnson & Johnson (J&J) baby talcum powder sold in the Kingdom does not contain harmful asbestos. The SFDA’s confirmation came after a person questioned the authority’s action, especially after Johnson & Johnson Company announced that it would cease production and … Get the latest updates in Hyderabad City News , Technology , Entertainment , Sports , Politics and Top Stories on WhatsApp & Telegram by subscribing to our channels. You can also download our app for Android and iOS .


Source:The Siasat Daily
Technical analysis: Will the Johnson and Johnson stock price continue retreating?
Aug 15, 2022 13:40pm

Sell Stop։ Below 166.95. Stop Loss: Above 171.82. Indicator Signal RSI Buy MACD Sell Donchian Channel Sell MA(200) Buy Fractals Sell Parabolic SAR Sel


Source:FXStreet
Top 5 2nd Quarter Trades of Cadence Bank
Aug 15, 2022 11:00am

Related Stocks: KO , BEN , PM , NTR , JNJ ,


Source:GuruFocus
Johnson & Johnson discontinues sale of talc-based baby powder worldwide
Aug 15, 2022 08:05am

Johnson Johnson announced it would stop selling its talc-based baby powder around the world starting next year. The New Jersey-based pharmaceutical industry company further revealed that it would be replacing the…


Source:EconoTimes
Johnson & Johnson to stop sale of talcum baby powder globally
Aug 15, 2022 07:30am

Talc-based Johnson''s Baby Powder will be discontinued globally in 2023, as Johnson & Johnson transitions its baby powder portfolio to cornstarch. Read more… | Send to a friend


Source:Bizcommunity
J&J cans talc powder globally as lawsuits multiply
Aug 15, 2022 03:03am

Pharmaceutical giant has been forced to pay $3.5bn in settlements so far to resolve cancer cases


Source:BusinessLIVE
Top 5 2nd Quarter Trades of COMMERCE BANK
Aug 15, 2022 01:00am

Related Stocks: AMGN , ETN , IPG , PXD , JNJ ,


Source:GuruFocus
Johnson & Johnson Stock: Here’s the Level to Buy, and It’s a Steal
Aug 12, 2022 18:01pm

Johnson & Johnson stock is hitting its lowest level since March. Here''s where it''s a steal of a deal.


Source:The Street
Johnson & Johnson to cease production of talc-based baby powder
Aug 12, 2022 16:59pm

Johnson & Johnson announced they will cease production of their talc-based baby powder.


Source:Sunday World
Why is Johnson & Johnson stopping its sale of talc-based baby powder?
Aug 12, 2022 16:26pm

A bottle of Johnson’s Baby Powder is displayed on April 15, 2011. Johnson & Johnson is ending production of its iconic talc-based Johnson’s Baby Powder, which has been embroiled in thousands of lawsuits claiming it caused cancer. Jeff Chiu, Associated Press In 2020, responding to tens of thousands of lawsuits, Johnson & Johnson stopped selling talc-based baby powder in the United States and Canada. The Guardian reported the company was sued on the allegation that the talc-based baby powder caused cancer, but the company responded by saying that it was confident in the safety of its products. But it wasn’t the first time Johnson & Johnson experienced product safety concerns. Now, the company has announced that it will stop selling talc-based baby powder worldwide by 2023 and replace it with their cornstarch based powder. Why was Johnson & Johnson sued for its baby powder? The company recalled 33,000 bottles of baby powder in 2019 because traces of asbestos were detected. Amid the lawsuits that it was dealing with during that time, The Guardian said that the company knew about the contamination of its products.


Source:Deseret
Johnson & Johnson to discontinue sale of talc-based baby powder from 2023 amid cancer lawsuits
Aug 12, 2022 15:22pm

J&J said it will switch to an all cornstarch-based version of the product. It has also reiterated its position that its baby powder is safe to use and ''does not cause cancer''.


Source:The Print India
Johnson & Johnson to stop selling talcum baby powder after cancer allegations
Aug 12, 2022 14:14pm

Johnson & Johnson announced on it would stop selling talcum-based baby powder on Friday, replacing their product with cornstrach instead. The talcum-based baby powder is scheduled to end its run in globally in 2023. The company said it stood behind the safety of its talcum powder, after allegations from tens of thousands of women who […] The post Johnson & Johnson to stop selling talcum baby powder after cancer allegations appeared first on UK Investor Magazine .


Source:UK Investor Magazine
J&J to end sales of baby powder with talc globally next year
Aug 12, 2022 11:53am

Johnson & Johnson is pulling baby powder containing talc worldwide next year after it did the same in the U.S. and Canada amid thousands of lawsuits claiming it had caused cancer


Source:ABC News
Johnson & Johnson to stop selling talc baby powder after 38,000 lawsuits claiming it caused cancer
Aug 12, 2022 11:43am

Pharmaceuticals giant Johnson & Johnson will stop selling its trademark talc-based baby powder worldwide as the company pays out billions of dollars to women claiming it causes cancer


Source:Daily Mail Online
Daily round-up, Aug 12: Tradenation couple charged; Singapore man gets life sentence for Newcastle murder; J&J to stop selling talc baby powder
Aug 12, 2022 11:33am

Let''s get you up to speed with the day''s stories. ‘Our mistake’ to flee Singapore: Couple accused of cheating in Tradenation luxury goods scam charged


Source:Channel NewsAsia
Wall Street Breakfast: New listed homes drop most since 2020
Aug 12, 2022 11:32am

Newly-listed homes drop most since 2020. Shell, Chevron shut six Gulf of Mexico oil platforms due to pipeline leakage. J&J, Merck, Regeneron most exposed to Medicare drug price negotiation


Source:Seeking Alpha
Drug stocks are sliding on fears of Zantac lawsuits — here''s what it means for JNJ
Aug 11, 2022 18:11pm

Here''s our estimate of what Johnson & Johnson''s potential exposure to this litigation could be in a worst-case scenario.


Source:CNBC
Blooom Inc. Acquires 837 Shares of Johnson & Johnson
Aug 11, 2022 10:51am

Blooom Inc. raised its holdings in Johnson & Johnson by 8.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm…


Source:Business Mag
Ken Fisher’s Fisher Asset Management Portfolio – Q2 2022 Update
Aug 11, 2022 01:38am

Ken Fisher’s 13F portfolio value decreased from ~$165B to ~$141B in Q2. Johnson & Johnson and Capital One Financial were increased while reducing Eli Lilly and Novo Nordisk this quarter.


Source:Seeking Alpha
Top 5 2nd Quarter Trades of GREAT WEST LIFE ASSURANCE CO /CAN/
Aug 10, 2022 23:00pm

Related Stocks: MSFT , JNJ , PG , MCD , PEP ,


Source:GuruFocus
Blue Chip Stocks In Focus: Johnson & Johnson
Aug 10, 2022 20:48pm

Published on August 10th, 2022 by Josh Arnold Healthcare tends to be a sector with a lot of great dividend stocks, because companies in the industry tend to have fairly defensive earnings profiles. It is no wonder then that dividend stock lists tend to have a fair number of healthcare companies as components. This is […] The post Blue Chip Stocks In Focus: Johnson & Johnson appeared first on Sure Dividend .


Source:Sure Dividend
J&J partner Aspen risks closure of COVID vaccine plant as orders dry up (OTCMKTS:APNHF)
Aug 10, 2022 20:02pm

South Africa-based Aspen Pharmacare (APNHF) (APNHY), which produces Johnson & Johnson (JNJ) COVID-19 vaccine, would soon have to pivot its production plant to manufacture other products…


Source:Seeking Alpha
News24.com | Aspen to halt Covid-19 vaccine production as J&J orders dry up
Aug 10, 2022 16:46pm

This will further undermine Africa''s already meagre capacity to produce doses.


Source:News24
The 3 Best Sectors for a Bear Market
Aug 10, 2022 16:36pm

This has not been a kind year for investors. In fact, the S&P 500 fell 21% in the first half of the year. Further, on June 13 the index officially fell into bear-market territory as it closed 20% below the highs it reached in January. That means investors should logically seek to buy stocks that are in the best sectors for a bear market. The current bear market has caused investors to rethink their strategies. Moreover, successive bouts of quantitative tightening have raised interest rates, changing the entire market landscape. Companies that were able to survive and in some cases even thrive despite their suspect fundamentals have seen the rug pulled out from underneath them. Meanwhile, previously high-flying growth stocks have suddenly had to deal with a sea change in which they have abruptly begun to be considered overvalued and their prices have plummeted. That’s what bear markets do. They also cause investors to seek out new stock sectors that looked relatively unappealing during bull markets.


Source:InvestorPlace
Aspen to halt Covid vaccine output as J&J orders dry up
Aug 10, 2022 13:16pm

Aspen has had no orders for its Aspenovax vaccine and has not received orders from Johnson & Johnson beyond August.


Source:Moneyweb News
Aspen to halt Covid-19 vaccine production as J&J orders dry up | Fin24
Aug 10, 2022 13:15pm

This will further undermine Africa''s already meager capacity to produce doses.


Source:News24
S.Africa''s Aspen to halt COVID vaccine output as J&J orders dry up
Aug 10, 2022 13:10pm

South Africa''s Aspen Pharmacare will stop making COVID-19 vaccines from the end of this month due to a lack of orders, a senior executive said, further undermining Africa''s already meager capacity to produce doses.


Source:Reuters
HCA Healthcare and Johnson & Johnson to collaborate on cardiovascular, cancer and health equity initiatives
Aug 09, 2022 19:27pm

The pair of health care giants will work to improve health equity, better support nurses and enhance patient care.


Source:Business Journals
HCA Healthcare Signs Strategic Collaboration With Johnson & Johnson
Aug 09, 2022 13:00pm

(RTTNews) - HCA Healthcare, Inc. (HCA), Thursday announced a collaboration with Johnson & Johnson (JNJ) to improve health equity, enhance nursing support, and improve patient outcomes.


Source:Nasdaq
Here’s Why ClearBridge Investments Invested in Johnson & Johnson (JNJ)
Aug 09, 2022 11:51am

ClearBridge Investments, an investment management company, released its “ClearBridge Sustainability Leaders Strategy” second quarter 2022 investor letter. A copy of the same can be downloaded here. The fund’s portfolio outperformed the Russell 3000 benchmark Index in the second quarter of 2022. Stock selection and sector allocation contributed to the fund’s performance. For more information on […]


Source:Insider Monkey
Mammen to depart J&J, leaving behind data science foundation
Aug 08, 2022 23:07pm

Seven new drug approvals, more than 30 label expansions and a deal-driven foundation in data science define the legacy that Mathai Mammen leaves at J&J…


Source:BioCentury
Cosmeceuticals & Dermatologists Market Is Going to Boom : L''Oreal, Unilever, P&G
Aug 08, 2022 15:54pm

Cosmeceuticals & Dermatologists Market 2022-2028 New Jersey, NJ -- ( SBWIRE ) -- 08/08/2022 -- The Latest research study released by HTF MI "Cosmeceuticals & Dermatologists Market" with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Some of the Major Companies covered in this Research are P&G, Shiseido, Unilever, Beiersdorf, L''Oreal, Johnson & Johnson, Estee Lauder, Allergan & AmorePacific etc. Click here for free sample + related graphs of the report @: https://www.htfmarketreport.com/sample-report/3845858-cosmeceuticals-dermatologists-market-1 Browse market information, tables and figures extent in-depth TOC on "Cosmeceuticals & Dermatologists Market by Application (Specialty Store, Supermarket, Drugstore & Other), by Product Type (, Skin Care, Hair Care, Injectables & Other), Business scope, Manufacturing and Outlook – Estimate to 2027". for more information or any query mail at sales@htfmarketreport.com At last, all parts of the Cosmeceuticals & Dermatologists Market are quantitatively also subjectively valued to think about the Global just as regional market equally.


Source:SBWire
Pyramid Biosciences Names Nushmia Khokhar, MD, as Chief Medical Officer
Aug 08, 2022 11:30am


Source:Kwhen Finance
South Africa reports first death linked to J&J COVID-19 vaccine
Aug 05, 2022 16:43pm

South Africa’s health authorities announced the first death linked to Johnson & Johnson’s COVID-19 vaccine. According to senior scientists, the vaccine caused this individual to develop the rare neurological disorder Guillain-Barre syndrome, after which he was placed on a ventilator and then passed away. South Africa administrated mostly J&J and Pfizer in its COVID-19 vaccination campaign. The American pharmaceutical company stopped producing the anti-COVID-19 vaccine for a while, as the single shot shows up in side effects. The post South Africa reports first death linked to J&J COVID-19 vaccine appeared first on HESPRESS English - Morocco News .


Source:Hespress English
South Africa records one death related to J&J COVID-19 vaccine
Aug 05, 2022 12:18pm

© Provided by Xinhua One person has died in South Africa due to Guillain Barre syndrome (GBS) after receipt of the Johnson & Johnson (J&J) COVID-19 vaccine since the start of vaccination in the country, the national health products regu


Source:Johannesburg News
Pharmaceutical CEOs use earnings calls to criticize drug-pricing proposal
Aug 05, 2022 11:29am

Executives at AbbVie, J&J, and Merck say the suggested changes in their current form would be ''chilling'' or ''detrimental'' to the development of new therapies.


Source:MarketWatch
Craniomaxillofacial Devices Market is projected to expand at a steady CAGR over the forecast by 2031 | DePuy Synthes (J&J), Stryker, Medtronic, Zimmer-Biomet
Aug 05, 2022 10:30am

New York, 2022-Jul-14 — /EPR Network/ — Global Craniomaxillofacial Devices Market report from Global Insight Services is the single authoritative source of intelligence on Craniomaxillofacial Devices Market. [read full press release…]


Source:Express Press Release Distribution
South Africa records one death related to J&J vaccine
Aug 05, 2022 08:47am

News Ghana, Latest Updates and Breaking News of Ghana, Xinhua, https://newsghana.com.gh/south-africa-records-one-death-related-to-jj-vaccine/One person has died in South Africa due to Guillain Barre syndrome (GBS) after receipt of the Johnson & Johnson (J&J) COVID-19 vaccine since the start of vaccination in the country, the national health products regulator said on Thursday. South African Health Products Regulatory Authority (SAHPRA) investigated about 160 deaths possibly associated with the vaccination […] News Ghana, Latest Updates and Breaking News of Ghana, Xinhua, https://newsghana.com.gh/south-africa-records-one-death-related-to-jj-vaccine/


Source:News Ghana